In Japan, drug quality audits are typically required every five years as part of Good Manufacturing Practice (GMP) compliance. However, the frequency may vary based on risk assessments, regulatory changes, or specific agreements with the Pharmaceuticals and Medical Devices Agency (PMDA). Companies often conduct internal audits more frequently to ensure compliance.
